SPAC959.11 Antibody

What is the SPAC959.11 protein and what is known about its function?

SPAC959.11 is a Schizosaccharomyces-specific protein found in Schizosaccharomyces pombe (strain 972 / ATCC 24843), commonly known as fission yeast. While its precise function remains under investigation, proteomic analyses have identified potential phosphorylation sites at residues S109, S114, and T116, suggesting it may be regulated through post-translational modifications . The protein may also be known by alternative names in certain databases, including "tam6" as noted in some genomic annotations .

Given its species specificity, researchers should consider SPAC959.11 as a potential marker for studying S. pombe-specific cellular processes. When designing experiments, it's advisable to cross-reference with the latest genomic databases as annotations and functional characterizations continue to evolve.

What applications has the SPAC959.11 antibody been validated for?

The SPAC959.11 antibody (product code CSB-PA520739XA01SXV) has been validated for several research applications:

• Western Blot (WB): For protein expression analysis and molecular weight confirmation

• Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative detection in solution

The antibody is specifically tested for reactivity with Schizosaccharomyces pombe (strain 972 / ATCC 24843) . When designing experiments, researchers should perform their own validation tests as application-specific optimizations may be necessary based on sample preparation and experimental conditions.

What is the recommended storage protocol for maintaining antibody activity?

For optimal preservation of SPAC959.11 antibody activity:

• Store at -20°C or -80°C upon receipt

• Avoid repeated freeze-thaw cycles, which can lead to antibody degradation and loss of binding capacity

• The antibody is supplied in a liquid formulation with preservatives (0.03% Proclin 300) and stabilizers (50% Glycerol, 0.01M PBS, pH 7.4)

For long-term storage planning, researchers should aliquot the antibody into smaller volumes based on typical experimental usage to minimize freeze-thaw events.

What are the recommended experimental controls when working with SPAC959.11 antibody?

For rigorous scientific validation, researchers should incorporate these controls when working with SPAC959.11 antibody:

Essential Controls Table:

This comprehensive control strategy enables confident interpretation of experimental results and effective troubleshooting if problems arise .

What dilution ranges should be tested when optimizing SPAC959.11 antibody for Western blotting?

When optimizing SPAC959.11 antibody for Western blotting applications, researchers should:

• Begin with a titration experiment using a dilution range of 1:500 to 1:5000 in blocking solution

• For the secondary antibody, use a consistent 1:5000 to 1:10000 dilution

• Establish optimal signal-to-noise ratio by comparing band intensity against background

• Once optimized, maintain consistent dilution across experiments for reproducible results

Blocking conditions should be optimized as well, testing both BSA and non-fat dry milk in PBS-T or TBS-T buffers, as these can significantly impact antibody binding efficiency and specificity.

How can SPAC959.11 antibody be used to study protein-protein interactions in S. pombe?

For analyzing protein-protein interactions involving SPAC959.11, co-immunoprecipitation (Co-IP) represents a powerful methodological approach:

Co-IP Protocol Overview:

• Prepare S. pombe lysates under non-denaturing conditions to preserve protein interactions

• Pre-clear lysate with Protein A/G beads to reduce non-specific binding

• Incubate cleared lysate with SPAC959.11 antibody (typically 2-5 μg antibody per 500 μg protein lysate)

• Capture immune complexes with Protein A/G beads

• Wash extensively with buffers containing low concentrations of non-ionic detergents

• Elute bound proteins and analyze by immunoblotting for potential interaction partners

For more stringent validation, researchers should consider:

• Performing reverse Co-IP using antibodies against suspected interaction partners

• Including appropriate negative controls (IgG, irrelevant antibodies)

• Confirming interactions using orthogonal techniques such as yeast two-hybrid or proximity ligation assays

What approaches are recommended for studying post-translational modifications of SPAC959.11?

Given the identified phosphorylation sites on SPAC959.11 (S109, S114, T116) , researchers can employ these methodological approaches:

For Phosphorylation Analysis:

• Phospho-specific antibody development: Consider generating phospho-specific antibodies against the identified sites if not commercially available

• Phosphatase treatment control: Treat duplicate samples with lambda phosphatase to confirm phosphorylation-dependent signals

• Mass spectrometry analysis: Perform immunoprecipitation followed by MS analysis for comprehensive PTM mapping

Experimental Design Considerations:

• Include phosphatase inhibitors in all lysis buffers

• Use Phos-tag™ SDS-PAGE for enhanced separation of phosphorylated species

• Compare PTM patterns under different physiological conditions to elucidate regulatory mechanisms

This multi-faceted approach allows comprehensive characterization of post-translational modifications and their functional significance .

How can researchers adapt high-throughput techniques for studying SPAC959.11 expression across multiple conditions?

Drawing from advanced methodologies used in antibody research , researchers can implement:

High-Throughput Analysis Framework:

• Array-based expression profiling using SPAC959.11 antibody across multiple S. pombe strains or conditions

• Automated liquid handling systems for standardized sample preparation

• Microfluidic Western blotting for minimal sample consumption and higher throughput

• Image analysis software for quantitative comparison across multiple samples

Data Integration Strategy:

• Correlate SPAC959.11 protein expression with transcriptomic data

• Implement bioinformatic pipelines to identify co-regulated proteins

• Apply machine learning algorithms to predict functional relationships

This systems biology approach enables comprehensive understanding of SPAC959.11 regulation and function within broader cellular networks .

What are common causes of high background when using SPAC959.11 antibody in immunoblotting?

High background issues when using SPAC959.11 antibody may stem from several methodological factors:

Common Causes and Solutions:

When facing persistent background issues, consider purifying the antibody using antigen-specific affinity methods to enhance specificity, similar to approaches used in other antibody research .

How should researchers interpret multiple bands when using SPAC959.11 antibody in Western blotting?

When multiple bands appear in Western blots using SPAC959.11 antibody, methodological interpretation should consider:

• Post-translational modifications: Given the identified phosphorylation sites (S109, S114, T116) , higher molecular weight bands may represent phosphorylated forms of SPAC959.11

• Protein isoforms: Alternative splicing or proteolytic processing may generate multiple protein variants

• Cross-reactivity: Non-specific binding to proteins with similar epitopes

Validation Approaches:

• Perform mass spectrometry analysis of each band

• Compare band patterns in wild-type vs. deletion strains

• Use recombinant SPAC959.11 protein as size reference

• Treat samples with phosphatases to determine if higher bands collapse

This systematic approach enables confident assignment of bands and extraction of meaningful biological information .

What factors contribute to lot-to-lot variability in polyclonal SPAC959.11 antibody performance?

Polyclonal antibodies like SPAC959.11 antibody (CSB-PA520739XA01SXV) may exhibit lot-to-lot variability due to:

• Immunization differences: Variation in animal immune responses across production batches

• Purification consistency: Subtle differences in affinity purification processes

• Epitope heterogeneity: Different antibody populations recognizing different epitopes on SPAC959.11 protein

Mitigation Strategies:

• Purchase sufficient quantity of a single lot for long-term studies

• Perform side-by-side validation of new lots against previous lots

• Maintain detailed records of antibody performance across experiments

• Consider developing monoclonal alternatives for highly sensitive applications

By addressing these variables methodically, researchers can maintain experimental reproducibility despite the inherent variability of polyclonal reagents .

How can SPAC959.11 antibody be used in CHIP-seq experiments to study DNA-protein interactions?

If SPAC959.11 is suspected to interact with chromatin or DNA-binding proteins, researchers can adapt chromatin immunoprecipitation sequencing (ChIP-seq) protocols:

Methodological Approach:

• Cross-link S. pombe cells with formaldehyde to preserve protein-DNA interactions

• Sonicate chromatin to generate 200-500bp fragments

• Perform immunoprecipitation with SPAC959.11 antibody

• Reverse cross-links and purify DNA

• Prepare libraries for next-generation sequencing

• Analyze data using bioinformatic pipelines to identify binding sites

Critical Considerations:

• Optimize chromatin shearing conditions specifically for S. pombe

• Include input controls and IgG controls for accurate peak calling

• Validate findings with ChIP-qPCR before proceeding to sequencing

• Consider epitope masking that may occur during chromatin association

This advanced application can reveal potential roles for SPAC959.11 in transcriptional regulation or genome organization .

What strategies can be employed to develop improved SPAC959.11 detection methods?

Drawing from advanced antibody development approaches , researchers could consider:

Next-Generation Detection Methods:

• Developing recombinant antibody fragments (Fab, scFv) against SPAC959.11 for improved specificity

• Engineering fluorescent protein-linked nanobodies for live-cell imaging

• Implementing multiplexed detection systems for simultaneous analysis of SPAC959.11 and interaction partners

• Adapting single-cell analysis techniques for studying SPAC959.11 expression heterogeneity

Development Strategy:

• Screen antibody libraries using high-throughput platforms similar to those used for therapeutic antibody development

• Apply structural biology approaches to identify optimal epitope targets

• Validate new reagents against multiple S. pombe strains and conditions

These advanced approaches represent the frontier of protein detection methodology and offer significant advantages for specialized research applications .